Volume 4, Issue 12, Pages (December 2017)

Slides:



Advertisements
Similar presentations
BEAT-IT: A randomised controlled trial comparing a behavioural activation treatment for depression in adults with learning disabilities with an attention.
Advertisements

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Volume 370, Issue 9586, Pages (August 2007)
Volume 390, Issue 10101, Pages (September 2017)
Volume 4, Issue 9, Pages (September 2017)
Volume 16, Issue 8, Pages (August 2017)
Volume 12, Issue 11, Pages (November 2013)
Volume 375, Issue 9729, Pages (May 2010)
Volume 1, Issue 7, Pages (December 2014)
Volume 4, Issue 7, Pages (July 2017)
Volume 11, Issue 4, Pages (April 2012)
Volume 378, Issue 9785, Pages (July 2011)
Volume 388, Issue 10042, Pages (July 2016)
Volume 388, Issue 10059, Pages (November 2016)
Volume 1, Issue 7, Pages (December 2014)
Volume 5, Issue 4, Pages (April 2006)
Volume 5, Issue 2, Pages (February 2018)
Volume 13, Issue 3, Pages (March 2012)
Volume 382, Issue 9886, Pages (July 2013)
Volume 16, Issue 8, Pages (August 2017)
Volume 5, Issue 2, Pages (February 2018)
Volume 4, Issue 7, Pages (July 2017)
Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data  David A Jolliffe, PhD,
Volume 388, Issue 10052, Pages (October 2016)
Volume 375, Issue 9732, Pages (June 2010)
Volume 389, Issue 10065, Pages (January 2017)
Volume 1, Issue 3, Pages (August 2014)
Volume 5, Issue 1, Pages (January 2018)
Volume 373, Issue 9663, Pages (February 2009)
Volume 4, Issue 2, Pages (February 2017)
Volume 388, Issue 10061, Pages (December 2016)
Volume 3, Issue 2, Pages (February 2016)
Volume 2, Issue 12, Pages (December 2015)
Volume 372, Issue 9642, Pages (September 2008)
Volume 2, Issue 6, Pages (June 2015)
Volume 9, Issue 10, Pages (October 2008)
Volume 2, Issue 9, Pages (September 2015)
Volume 5, Issue 9, Pages (September 2018)
Volume 4, Issue 2, Pages (February 2017)
Volume 388, Issue 10059, Pages (November 2016)
Volume 377, Issue 9768, Pages (March 2011)
Volume 378, Issue 9801, Pages (October 2011)
Volume 4, Issue 6, Pages (June 2017)
Effectiveness of the Healthy Lifestyles Programme (HeLP) to prevent obesity in UK primary-school children: a cluster randomised controlled trial  Jenny.
Volume 378, Issue 9785, Pages (July 2011)
Volume 384, Issue 9938, Pages (July 2014)
Volume 386, Issue 10011, Pages (December 2015)
Volume 12, Issue 8, Pages (August 2013)
Volume 388, Issue 10058, Pages (November 2016)
Volume 388, Issue 10047, Pages (August 2016)
Volume 381, Issue 9868, Pages (March 2013)
Volume 5, Issue 8, Pages (August 2018)
Volume 388, Issue 10042, Pages (July 2016)
Volume 3, Issue 6, Pages (June 2016)
Volume 3, Issue 2, Pages (February 2016)
Volume 5, Issue 2, Pages (February 2018)
Volume 15, Issue 13, Pages (December 2014)
Volume 5, Issue 4, Pages (April 2018)
Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial  Dr.
Volume 375, Issue 9732, Pages (June 2010)
Volume 375, Issue 9714, Pages (February 2010)
Volume 7, Issue 8, Pages (August 2008)
Volume 13, Issue 12, Pages (December 2014)
Volume 381, Issue 9878, Pages (May 2013)
Volume 378, Issue 9802, Pages (October 2011)
Volume 372, Issue 9632, Pages (July 2008)
Volume 1, Issue 1, Pages (June 2014)
Volume 14, Issue 7, Pages (June 2013)
Volume 3, Issue 1, Pages (January 2016)
Volume 1, Issue 7, Pages (December 2014)
Presentation transcript:

Volume 4, Issue 12, Pages 909-919 (December 2017) Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: a randomised controlled trial  Prof Andrew Jahoda, PhD, Prof Richard Hastings, PhD, Prof Chris Hatton, PhD, Prof Sally-Ann Cooper, MD, Prof Dave Dagnan, PhD, Ruiqi Zhang, MSc, Alex McConnachie, PhD, Nicola McMeekin, MSc, Kim Appleton, PhD, Prof Rob Jones, PhD, Katie Scott, MSc, Lauren Fulton, MA, Rosie Knight, MSc, Dawn Knowles, MSc, Chris Williams, PhD, Prof Andrew Briggs, PhD, Ken MacMahon, PhD, Helen Lynn, PhD, Ian Smith, DClinPsy, Gail Thomas, DClinPsy, Prof Craig Melville, MD  The Lancet Psychiatry  Volume 4, Issue 12, Pages 909-919 (December 2017) DOI: 10.1016/S2215-0366(17)30426-1 Copyright © 2017 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile SSSFT=South Staffordshire and Shropshire Healthcare NHS Foundation Trust. IQ=intelligence quotient. Participants recruited within SSSFT were randomly assigned through the Wales study site. *Includes one participant initially allocated to StepUp in error. Data were removed from analysis. The Lancet Psychiatry 2017 4, 909-919DOI: (10.1016/S2215-0366(17)30426-1) Copyright © 2017 Elsevier Ltd Terms and Conditions

Figure 2 Effect estimates and 95% CIs at 12 months The forest plot shows effect sizes and 95% CIs for the primary and secondary outcomes for both groups of the study. Effect sizes were calculated as the estimated between-group differences for each outcome at each timepoint, divided by the SD of the outcome measure at baseline across all participants. Measurements were taken at baseline and 12 months. GDS-LD=Glasgow Depression Scale for people with Learning Disabilities. IDDS=Intellectual Disabilities Depression Scale. GAS-ID=Glasgow Anxiety Scale for people with Intellectual Disabilities. BPI-S=Behaviour Problems Inventory for Individuals with Intellectual Disabilities, short form. EQ-5D-Y=EuroQol five-dimensional questionnaire, Youth version. EQ-5D-VAS=EuroQol five-dimensional questionnaire Visual Analogue Scale. ICI=Index of Community Involvement. IPDL=Index of Participation in Domestic Life. SSQ3=Social Support Questionnaire. ABS=Adaptive Behavior Scale (Residential and Community: second edition). EDSE=Emotional Difficulties Self-Efficacy Scale. BLESID=Bangor Life Events Schedule for Intellectual Disabilities. *Where a decrease in score indicated a positive change, effect sizes were reported as positives (GDS-LD, IDDS, GAS-ID, BPI-S, and BLESID had negative effect sizes, indicating a positive change). The Lancet Psychiatry 2017 4, 909-919DOI: (10.1016/S2215-0366(17)30426-1) Copyright © 2017 Elsevier Ltd Terms and Conditions

Figure 3 Cost-effectiveness plane (multiple imputation, adjusted results) The Lancet Psychiatry 2017 4, 909-919DOI: (10.1016/S2215-0366(17)30426-1) Copyright © 2017 Elsevier Ltd Terms and Conditions